Published on 31 Oct 2023 on Zacks via Yahoo Finance
Kiniksa Pharmaceuticals, Ltd. (KNSA) Reports Q3 Loss, Tops Revenue Estimates
Kiniksa Pharmaceuticals, Ltd. (KNSA) came out with a quarterly loss of $0.20 per share versus the Zacks Consensus Estimate of a loss of $0.18. This compares to earnings of $0.67 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of -11.11%. A quarter ago, it was expected that this company would post a loss of $0.16 per share when it actually produced a loss of $0.02, delivering a surprise of 87.50%.
Over the last four quarters, the company has surpassed consensus EPS estimates two times.